FDA Approved: PALYNZIQ — Supplemental Application (BioMarin Pharmaceutical Inc.)

View source ↗

Summary

The FDA approved BioMarin's supplemental application for Palynziq (pegvaliase-pqpz), updating the existing approval for phenylketonuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• PALYNZIQ (PEGVALIASE-PQPZ)

Snippet

SUPPL AP for PALYNZIQ (PEGVALIASE-PQPZ)